Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192200 | PMC |
http://dx.doi.org/10.2217/fon-2020-0312 | DOI Listing |
Objectives: To explore the impact of the SARS-CoV-2/COVID-19 pandemic on the diagnosis, management and patient journey for children and young people with a newly diagnosed brain tumour in the UK.
Design: Exploratory qualitative study focused on patient journeys from multiple perspectives, conducted as part of a wider mixed-methods study.
Setting: Three paediatric oncology tertiary centres in the UK.
Bull Cancer
February 2025
INSERM, Aix Marseille université, IRD, ISSPAM, SESSTIM, sciences économiques et sociales de la santé et traitement de l'information médicale, équipe CALIPSO, 27, boulevard Jean-Moulin, 13385 Marseille cedex, France.
For the past decade, "long-term follow-up consultations" have been established for adults cured of pediatric cancer to ensure the prevention, early detection, and treatment of long-term effects. These consultations are now sometimes conducted in the form of teleconsultations, a practice that has seen significant growth following the COVID-19 crisis. The objective of this study was to evaluate the satisfaction, usefulness, and patient experience of teleconsultations conducted by an oncologist or hematologist as part of the long-term follow-up of adults cured of pediatric cancer.
View Article and Find Full Text PDFBull Cancer
February 2025
Service d'oncologie hématologie pédiatrique, hôpital universitaire Armand-Trousseau (AP-HP), Paris, France; Centre d'investigations cliniques, hôpital Cochin, Paris, France. Electronic address:
Children and adolescents who are being treated or have been treated for acute leukemia have a secondary immunodeficiency linked to chemotherapy, resulting in an increased risk of infections. Some of which can be prevented by vaccination but its effectiveness is not optimal during chemotherapy. Upon cessation of chemotherapy, the time required for immune reconstitution varies from three months to more than a year, depending on lymphocyte subpopulations, the patient's age, and the intensity of the treatment received.
View Article and Find Full Text PDFSupport Care Cancer
December 2024
Pain Therapy Unit, Department of Anaesthesiology and Intensive Care Medicine, University Hospital Ulm, Albert-Einstein-Allee 23, 89075, Ulm, Germany.
Purpose: The increasing survival rates of oncology patients have led to a corresponding increase in long-time survivors living with chronic cancer-related pain. Data is scarce on the care situation for this distinct clinical entity and on specific therapy requirements, such as interdisciplinary, multimodal pain therapy (IMPT). Our cross-sectional study aimed to assess the current care situation, distinct chronification factors, and optimization potential.
View Article and Find Full Text PDFInt J Lang Commun Disord
December 2024
University of Liverpool & Liverpool Head and Neck Centre, Liverpool, UK.
Background: Over 200,000 patients are referred onto the suspected head and neck cancer (HNC) pathway annually in the UK, with around 3% receiving a cancer diagnosis. With new HNC advancements in identifying patients at low risk of a cancer diagnosis, one proposal is a speech and language therapy (SLT)-led first point of contact clinic for low-risk patients presenting with voice or swallowing symptoms.
Aims: To explore ear, nose and throat (ENT) surgeons' views regarding this model.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!